UNSPSC 51284043: Tetracycline hydrochloride

This classification denotes a tetracycline antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier P6R62377KV. European Medicines Agency schedules Tetracycline hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04760MIG. Tetracycline hydrochloride generally arises in the molecular formula C22H24N2O8.CLH. The term 'tetracycline hydrochloride' is a U.S. Pharmacopeial Convention designation.

UNSPSC 51284043 Tetracycline hydrochloride, a Commodity code, shows limited alignment between its abstract scope and recent state and local solicitation activity. The code nominally identifies a specific antibiotic pharmaceutical; however, the recent opportunities tagged to it reflect broader pharmaceutical procurement including naloxone, medical and first aid supplies for emergency response, and multi-source generic pharmaceuticals and over-the-counter products distributed through state cooperative purchasing arrangements. State and local governments buying under this code area are primarily health departments, fire rescue divisions, and state pharmacy benefit programs using cooperative purchasing vehicles. Issuing bodies include county health departments (Seminole County, Florida), municipal fire departments (City of Tampa), and state agencies administering multi-jurisdictional pharmaceutical contracts (Texas Health and Human Services Commission, Minnesota Department of Administration through MMCAP). The scope of work encompasses emergency-response pharmaceuticals and medical consumables, generic prescription pharmaceuticals with FDA compliance and cGMP certification, and OTC products distributed via authorized pharmaceutical wholesalers.

Recent activity appears concentrated in Florida and Minnesota, with emerging interest in Texas through a market-research RFI. Representative opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries and a two-year initial term; the City of Tampa's IFB 26P00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division with an estimated contract value of $700,000, designated as a sheltered market for certified Small Local Business Enterprises with a 5 percent bid discount cap of $10,000; and MMCAP's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) establishing multi-award contracts for generic pharmaceuticals and OTC products across Minnesota and Oregon member jurisdictions, requiring 3 percent administrative fee participation and mandatory relationships with authorized wholesalers AmerisourceBergen (Cencora), Cardinal Health, or Morris & Dickson. Texas HHS issued RFI HHS0017013 (posted April 3, 2026) to gather vendor capabilities for direct-to-manufacturer pharmacy programs, signaling exploratory procurement activity before formal solicitation.